Hepatobiliary & Pancreatic Diseases International(2024年03期)
国际肝胆胰疾病杂志(英文版)

目 录

• Information for Readers
• Instructions for Authors
• Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus:State of art and future perspectives
• Emerging role of regulated cell death in intestinal failure-associated liver disease
• Mirizzi syndrome:Problems and strategies
• Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease
• Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma:A prospective multicenter cohort study
• Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma
• Non-anatomical liver resection for hepatocellular carcinoma:the SegSubTe classification to overcome the problem of heterogeneity
• A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma:Construction and analysis of a circRNA-me diate d competing endogenous RNA network
• Development and validation of a nomogram model for predicting the risk of gallstone recurrence after gallbladder-preserving surgery
• Acute suppurative terminal cholangitis:Clinical characteristics of a new subtype of acute cholangitis
• Mesenteric adipose tissue B lymphocytes promote intestinal injury in severe acute pancreatitis by mediating enteric pyroptosis
• Mechanisms of liver injuries caused by traditional Chinese medicines
• Tri-modal death distribution towards personalized management of intraductal papillary neoplasm of the bile duct patients:Every story has its own conclusion
• Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach
• Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis
• Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment
• Meetings and Courses
• Hepatobiliary u0026 Pancreatic Diseases International
• the First Affiliated Hospital,Zhejiang University School of Medicine(FAHZU)